Sarah Rodgers
Has grant
Head of Research Services
United KingdomResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Sarah Rodgers is the Head of Research Services at the University of Nottingham, UK. Her research focuses on medication safety, particularly in the context of the COVID-19 pandemic and its implications for primary care. Notable contributions include studies on hazardous prescribing interventions and avoidable harm in healthcare settings, emphasizing the integration of advanced analytics in improving patient safety.
Recent Grants
Grant: Close
Avoiding patient harm through the application of prescribing safety indicators in English general practices (acronym: PRoTeCT)
Open Date: 2017-03-01
Close Date: 2022-02-01
Grant: Close
Developing and evaluating a measure of inappropriate polypharmacy in primary care: RAND appropriateness and CPRD epidemiological study.
Open Date: 2016-07-01
Close Date: 2018-06-01
Grant: Close
Exploring the views of key stakeholders on an intervention aimed at improving the safety of prescribing of GP Associates in training.
Open Date: 2016-07-01
Close Date: 2017-12-01
Grant: Close
Understanding the Nature and Frequency of Avoidable Harm in Primary Care.
Open Date: 2015-04-01
Close Date: 2017-03-01
Grant: Close
Improving prescribing safety in general practices in the East Midlands through the PINCER intervention.
Open Date: 2015-01-01
Close Date: 2018-06-01
Articles (3)
Year:
2023
Year:
2022
Year:
2021
Collaborators (9)
thomas allen
The University of Manchester
Rachel Ann Elliott
The University of Manchester
Steve Roberts
University of Manchester
Helen Curtis
University of Oxford
Louis Fisher
University of Oxford
Matthew Boyd
University of Nottingham
Christina Sheehan
University of Nottingham
Alex Walker
University of Oxford
Ben Goldacre
University of Oxford
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.